Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis

被引：16

作者：

Donald, Michael B. ^{[3
]}

Rodriguez, Kevin X. ^{[3
]}

Shay, Hannah ^{[3
]}

Phuan, Puay-Wah ^{[1
,2
]}

Verkman, A. S. ^{[1
,2
]}

Kurth, Mark J. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA

[3] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 17期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

CuAAC; Triazolobithiazole; Cystic fibrosis; CF corrector; TRANSMEMBRANE CONDUCTANCE REGULATOR;

D O I：

10.1016/j.bmc.2012.06.046

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5'-bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96). (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：5247 / 5253

页数：7

共 50 条

[41] Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening
Kalid, Ori
Mense, Martin
Fischman, Sharon
Shitrit, Alina
Bihler, Hermann
Ben-Zeev, Efrat
Schutz, Nili
Pedemonte, Nicoletta
Thomas, Philip J.
Bridges, Robert J.
Wetmore, Diana R.
Marantz, Yael
Senderowitz, Hanoch
[J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (12) : 971 - 991
[42] Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
Saint-Criq, Vinciane
Wang, Yiting
Delpiano, Livia
Lin, JinHeng
Sheppard, David N.
Gray, Michael A.
[J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (05) : 843 - 850
[43] Identification of novel F508del-CFTR traffic correctors among triazole derivatives
Bacalhau, Mafalda
Ferreira, Filipa C.
Kmit, Arthur
Souza, Felipe R.
da Silva, Veronica D.
Pimentel, Andre S.
Amaral, Margarida D.
Buarque, Camilla D.
Lopes-Pacheco, Miqueias
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 938
[44] The V510D Suppressor Mutation Stabilizes ΔF508-CFTR at the Cell Surface
Loo, Tip W.
Bartlett, M. Claire
Clarke, David M.
[J]. BIOCHEMISTRY, 2010, 49 (30) : 6352 - 6357
[45] Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action
Phuan, Puay-Wah
Veit, Guido
Tan, Joseph A.
Finkbeiner, Walter E.
Lukacs, Gergely L.
Verkman, A. S.
[J]. MOLECULAR PHARMACOLOGY, 2015, 88 (04) : 791 - 799
[46] NHE-RF1 protein rescues ΔF508-CFTR function
Bossard, Florian
Robay, Amal
Toumaniantz, Gilles
Dahimene, Shehrazade
Becq, Frederic
Merot, Jean
Gauthier, Chantal
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (05) : L1085 - L1094
[47] Ouabain mimics low temperature rescue of F508del-CFTR in cystic fibrosis epithelial cells
Zhang, Donglei
Ciciriello, Fabiana
Anjos, Suzana M.
Carissimo, Annamaria
Liao, Jie
Carlile, Graeme W.
Balghi, Haouaria
Robert, Renaud
Luini, Alberto
Hanrahan, John W.
Thomas, David Y.
[J]. FRONTIERS IN PHARMACOLOGY, 2012, 3
[48] Can Correcting the ΔF508-CFTR Proteostasis-Defect Rescue CF Lung Disease?
Valle, C. W.
Vij, N.
[J]. CURRENT MOLECULAR MEDICINE, 2012, 12 (07) : 860 - 871
[49] A Stabilizing Influence: CAL PDZ Inhibition Extends the Half-Life of ΔF508-CFTR
Cushing, Patrick R.
Vouilleme, Lars
Pellegrini, Maria
Boisguerin, Prisca
Madden, Dean R.
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (51) : 9907 - 9911
[50] Localisation of wild-type and ΔF508-CFTR in nasal epithelial cells
Dormer, RL
McNeilly, CM
Morris, MR
Pereira, MMC
Doull, IJM
Becq, F
Mettey, Y
Vierfond, JM
McPherson, MA
[J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 443 : S117 - S120

← 1 2 3 4 5 →